<DOC>
	<DOCNO>NCT00415714</DOCNO>
	<brief_summary>The objective study determine efficacy portable biofeedback device improve sleep latency sleep variable nocturnal awake time daytime functioning person primary insomnia .</brief_summary>
	<brief_title>Safety Efficacy Ambulatory Biofeedback Device Primary Insomnia</brief_title>
	<detailed_description>There evidence compare normal control , person insomnia exhibit increase cognitive physiological arousal high overall metabolic rate sleep , particularly sleep onset . There evidence reduce arousal may impact sleep latency nocturnal awake time . Although relaxation treatment integrated behavioral therapy , numerous barrier implementation real world setting . The present study design examine effect portable biofeedback device design induce physiological relaxation compare inactive sham control device condition reduce sleep onset latency person primary insomnia 4 week period three separate research site .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>1 . Between age 1855 2 . Met DSMIVTR criterion Primary Insomnia measure : Structured Interview Sleep Disorders . Insomnia Severity Index ( &gt; 14 ) . 3 . Demonstrate Sleep Onset Latency &gt; =45 minute &gt; = 3 night per week great equal 6 day 2 week period . 4 . A mean SOL &gt; = 30 minute 2 week period Screening Baseline visit . 5 . Residential stability ( 1 year ) mean travel appointment . 6 . Willing provide name contact information secondary contact person . 7 . Off insomnia medication least one week prior randomization 2 day use first week baseline . 8 . Ability read English . 9 . Provision informed consent . 10 . Willing comply daily protocol . 11 . Ability obtain reading device . 1 . Been 2 study past 2 year 2 . Pregnant 3 . Terminal , progressive , unstable medical illness . 4 . Selfreported sleep disruptive medical disorder . Chronic Pain , Fibromyalgia , Pheochromocytoma , Hyperthyroidism , Congestive Heart Failure , Chronic Obstructive Pulmonary Disease , Diabetes . 5 . Current Axis I psychiatric disorder . ( DSMIV ) . Major Depressive Disorder , Depression , Generalized Anxiety Disorder , Attention Deficit Disorder , Post Traumatic Stress Disorder , Bipolar Disorder , Substance/Alcohol Use Disorders , Attention Deficit Hyperactivity Disorder , Schizophrenia/Psychotic Disorders , Delirium , Dementia , and/or Amnesic disorder , Panic Disorder w/ nocturnal panic attack . 6 . Chronic alcohol use diagnose criterion 6. . Subjects unwilling limit alcohol intake 2 standard drink per day exclude . 7 . Raynaud â€™ Disease 8 . Regularly take antianxiety medication , beta blocker heart medication regulate heartbeat , bronchodilator , respiratory stimulant , simulate antidepressant , sedate antidepressant , thyroid supplement , antipsychotic , and/or steroid . 9 . Regularly take antidepressant ( Prozac , Zoloft , Paxil ) NOT fix dosage least 1 month prior enter study . 10 . Regularly take medication ( prescribed counter ) sleep difficulty ( &gt; 3x week ) . Sleep medication include substance sleep limit include FDA approve sleep medication , analgesic , antihistamine , decongestant , melatonin , Ltrypotophan , velarian . 11 . Unwilling abstain PRN sleep aide ( prescribed counter ) . 12 . Restless Leg Syndrome assess structure interview . 13 . Symptoms Sleep Apnea ( BMI &gt; 32 Epworth Sleepiness Scale &gt; 10 ) 14 . Own negative air ionizer use one past treat insomnia . 15 . If subject recognize device ability obtain pulse rate wave reading device . 16 . More 5 cup ( 8oz ) caffeinated drink per day and/or unwilling limit caffeine intake maximum 3 cup day 5pm intervention . 17 . Regular nighttime shift work rotate nighttime shift work . 18 . Idiopathic Insomnia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Primary Insomnia</keyword>
	<keyword>Chronic Insomnia</keyword>
	<keyword>Biofeedback</keyword>
	<keyword>Sleeplessness</keyword>
</DOC>